Condition
Pulmonary Tuberculosis clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Pulmonary Tuberculosis clinical trials that are recruiting, at sites in 14 countries (most in South Africa (2), Tanzania (2), Uganda (2)). 1 was first registered in the last 30 days. By phase: Phase 3 (3), Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1New in 30 days
- 14Countries
Newest Pulmonary Tuberculosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Channa striata and Curcuma Domestica Supplements in Active Pulmonary TB | — | Medan, North Sumatera and 1 other locations | Recruiting | Oct 21, 2026 |
| PAN-USR: a universal ultra-short treatment for pulmonary tuberculosis | Phase 3 | Beijing and 2 other locations | Recruiting | Apr 1, 2025 |
| Shorter treatment for low-risk active tuberculosis | Phase 3 | New Taipei City, Bangiao and 7 other locations | Recruiting | Dec 11, 2024 |
| Using breath analysis to identify multiple lung diseases | — | Guangzhou, Guangdong | Recruiting | Jul 30, 2024 |
| Using Atorvastatin to treat Pulmonary Tuberculosis | Phase 2 | Zaria, Kaduna State and 7 other locations | Recruiting | Jan 10, 2024 |
| Rehabilitation for people recovering from tuberculosis lung disease | — | Rio de Janeiro and 1 other locations | Recruiting | Nov 13, 2023 |
| New treatments for pulmonary tuberculosis | Phase 2 | Chisinau and 10 other locations | Recruiting | Nov 2, 2023 |
| Comparing new treatments for drug-sensitive pulmonary tuberculosis | Phase 2 | Lambaréné and 9 other locations | Recruiting | Apr 11, 2023 |
| High-dose treatment for recurrent tuberculosis | Phase 3 | Niamey | Recruiting | Feb 7, 2020 |
All recruiting trials (9)
-
Channa striata and Curcuma Domestica Supplements in Active Pulmonary TB
This study tests whether adding Channa striata extract and Curcuma domestica to standard TB care helps improve nutrition, inflammation, and quality of life in adults with active pulmonary tuberculosis.
-
PAN-USR: a universal ultra-short treatment for pulmonary tuberculosis
This trial tests whether a new 2–3 month drug regimen works and is safe for adults with active pulmonary tuberculosis, including drug-resistant cases.
-
Shorter treatment for low-risk active tuberculosis
This study is testing if a shorter 4-month treatment for low-risk pulmonary tuberculosis works just as well as the usual 6-month treatment for newly diagnosed patients.
-
Using breath analysis to identify multiple lung diseases
This study is testing if analyzing breath samples can help identify different lung diseases like lung cancer and COPD in a large group of 10,000 people.
-
Using Atorvastatin to treat Pulmonary Tuberculosis
This study is testing if adding Atorvastatin, a cholesterol-lowering drug, can help people with pulmonary tuberculosis get better when they start treatment.
-
Rehabilitation for people recovering from tuberculosis lung disease
This study is testing if a 12-week rehabilitation program can help people recovering from tuberculosis lung disease feel better and improve their daily activities compared to standard care.
-
New treatments for pulmonary tuberculosis
This study is testing new combinations of two drugs with existing TB treatments to see if they can help people with pulmonary tuberculosis get better in a shorter time than the usual 24 weeks.
-
Comparing new treatments for drug-sensitive pulmonary tuberculosis
This study is testing new treatment options for adults with drug-sensitive pulmonary tuberculosis to see if they work better than the standard treatment.
-
High-dose treatment for recurrent tuberculosis
This study is testing a higher dose of a new treatment for people with recurring tuberculosis to see if it works as well as the standard treatment.
Related topics
Quick answers
How many Pulmonary Tuberculosis clinical trials are recruiting right now?
9, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in South Africa (2 trials), Tanzania (2 trials), Uganda (2 trials), China (2 trials), Niger (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.